Literature DB >> 12122043

Enhanced inhibition of synaptic transmission by dopamine in the nucleus accumbens during behavioral sensitization to cocaine.

Corinne Beurrier1, Robert C Malenka.   

Abstract

Neural adaptations in the nucleus accumbens (NAc), a key component of the mesolimbic dopamine (DA) system, are thought to mediate several of the long-term behavioral sequelas of chronic in vivo exposure to drugs of abuse. Here, we examine whether the modulation of excitatory synaptic transmission by DA in the NAc shell is modified after chronic cocaine exposure that induced behavioral sensitization. The DA-induced inhibition of AMPA receptor-mediated synaptic responses was enhanced in cocaine-treated mice, an effect that was caused by activation of D1-like receptors. DA did not enhance NMDA receptor-mediated synaptic responses in saline- and cocaine-treated mice or in the dorsal striatum of control mice. We hypothesize that the enhanced inhibitory effects of DA on synaptic transmission in the NAc are one of a number of adaptations that contribute to a decrease in excitatory drive to NAc after exposure to drugs of abuse.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12122043      PMCID: PMC6757953          DOI: 20026625

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  31 in total

1.  Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior.

Authors:  Krista McFarland; Christopher C Lapish; Peter W Kalivas
Journal:  J Neurosci       Date:  2003-04-15       Impact factor: 6.167

2.  Acute amphetamine exposure selectively desensitizes kappa-opioid receptors in the nucleus accumbens.

Authors:  Yan-fang Xia; Li He; Jennifer L Whistler; Gregory O Hjelmstad
Journal:  Neuropsychopharmacology       Date:  2007-06-06       Impact factor: 7.853

3.  Group I mGluRs and long-term depression: potential roles in addiction?

Authors:  Brad A Grueter; Zoé A McElligott; Danny G Winder
Journal:  Mol Neurobiol       Date:  2007-07-27       Impact factor: 5.590

4.  Genetic NMDA receptor deficiency disrupts acute and chronic effects of cocaine but not amphetamine.

Authors:  Amy J Ramsey; Aki Laakso; Michel Cyr; Tatyana D Sotnikova; Ali Salahpour; Ivan O Medvedev; Linda A Dykstra; Raul R Gainetdinov; Marc G Caron
Journal:  Neuropsychopharmacology       Date:  2008-01-09       Impact factor: 7.853

Review 5.  Synaptic plasticity in the mesolimbic system: therapeutic implications for substance abuse.

Authors:  Billy T Chen; F Woodward Hopf; Antonello Bonci
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

Review 6.  Estradiol: a key biological substrate mediating the response to cocaine in female rats.

Authors:  Annabell C Segarra; José L Agosto-Rivera; Marcelo Febo; Natasha Lugo-Escobar; Raissa Menéndez-Delmestre; Anabel Puig-Ramos; Yvonne M Torres-Diaz
Journal:  Horm Behav       Date:  2009-12-21       Impact factor: 3.587

7.  Altered GluA1 (Gria1) Function and Accumbal Synaptic Plasticity in the ClockΔ19 Model of Bipolar Mania.

Authors:  Puja K Parekh; Darius Becker-Krail; Poornima Sundaravelu; Shinsuke Ishigaki; Haruo Okado; Gen Sobue; Yanhua Huang; Colleen A McClung
Journal:  Biol Psychiatry       Date:  2017-06-27       Impact factor: 13.382

8.  A single in vivo exposure to cocaine abolishes endocannabinoid-mediated long-term depression in the nucleus accumbens.

Authors:  Lawrence Fourgeaud; Susana Mato; Delphine Bouchet; Agnès Hémar; Paul F Worley; Olivier J Manzoni
Journal:  J Neurosci       Date:  2004-08-04       Impact factor: 6.167

9.  Extrasynaptic targeting of NMDA receptors following D1 dopamine receptor activation and cocaine self-administration.

Authors:  Pavel I Ortinski; Jill R Turner; R Christopher Pierce
Journal:  J Neurosci       Date:  2013-05-29       Impact factor: 6.167

10.  Ciliary neurotrophic factor protects striatal neurons against excitotoxicity by enhancing glial glutamate uptake.

Authors:  Corinne Beurrier; Mathilde Faideau; Khaled-Ezaheir Bennouar; Carole Escartin; Lydia Kerkerian-Le Goff; Gilles Bonvento; Paolo Gubellini
Journal:  PLoS One       Date:  2010-01-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.